PSA screening for prostate cancer

¹

2021

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…In contrast, the binding to the endothelin B receptor ETBR results in its clearance and cellular apoptosis. In accordance, Nelson, et al reported a downregulation in aggressive variants of prostate cancers (PCa) [5]. Such down-regulation of ETBR is based on promotor methylation [3].…”

Section: Introduction

mentioning

confidence: 64%

A new Prostate Cancer Surrogate Marker-Vimentin3?

¹

2021

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…In contrast, the binding to the endothelin B receptor ETBR results in its clearance and cellular apoptosis. In accordance, Nelson, et al reported a downregulation in aggressive variants of prostate cancers (PCa) [5]. Such down-regulation of ETBR is based on promotor methylation [3].…”

Section: Introduction

mentioning

confidence: 64%

Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer

Chen

¹

,

Ma

²

,

Liu

³

et al. 2021

J. Cancer

Smart CitationsHow this paper cites the one you are viewing

“…The treatment of PCa imposes a huge economic burden on patients and society [23]. Although many PCa patients can benefit from techniques such as prostate-specific antigen (PSA) screening, the time between tumor progression to biochemical recurrence and tumor metastasis remains unpredictable [24]. Most PCa patients eventually relapse due to castration-resistant prostate cancer, with tumor metastasis and more malignant invasive events [25].…”

Section: Discussion

mentioning

confidence: 99%

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage

¹

,

Peng

²

,

³

et al. 2018

Clin Epigenet

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…CEA, CA199, and CA125 were generally accepted to be validated to have positive predictive value as circulating biomarkers for different cancers. Other screening strategies include mammography for breast cancer [ 64 , 65 ], colonoscopy for CRC [ 66 ], and prostate-specific antigen (PSA) for prostate cancer [ 67 ]. However, still missing are more effective, accurate, specific, and sensitive screening biomarkers to fulfill the detective and predictive functions in the care of cancer patients.…”

Section: The Advantage Of Circulating Mirnas As Diagnosis and Prognos

mentioning

confidence: 99%

A new Prostate Cancer Surrogate Marker-Vimentin3?

¹

2021

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…In contrast, the binding to the endothelin B receptor ETBR results in its clearance and cellular apoptosis. In accordance, Nelson, et al reported a downregulation in aggressive variants of prostate cancers (PCa) [5]. Such down-regulation of ETBR is based on promotor methylation [3].…”

Section: Introduction

mentioning

confidence: 64%

Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer

Chen

¹

,

Ma

²

,

Liu

³

et al. 2021

J. Cancer

Smart CitationsHow this paper cites the one you are viewing

“…The treatment of PCa imposes a huge economic burden on patients and society [23]. Although many PCa patients can benefit from techniques such as prostate-specific antigen (PSA) screening, the time between tumor progression to biochemical recurrence and tumor metastasis remains unpredictable [24]. Most PCa patients eventually relapse due to castration-resistant prostate cancer, with tumor metastasis and more malignant invasive events [25].…”

Section: Discussion

mentioning

confidence: 99%

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage

¹

,

Peng

²

,

³

et al. 2018

Clin Epigenet

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…CEA, CA199, and CA125 were generally accepted to be validated to have positive predictive value as circulating biomarkers for different cancers. Other screening strategies include mammography for breast cancer [ 64 , 65 ], colonoscopy for CRC [ 66 ], and prostate-specific antigen (PSA) for prostate cancer [ 67 ]. However, still missing are more effective, accurate, specific, and sensitive screening biomarkers to fulfill the detective and predictive functions in the care of cancer patients.…”

Section: The Advantage Of Circulating Mirnas As Diagnosis and Prognos

mentioning

confidence: 99%

A new Prostate Cancer Surrogate Marker-Vimentin3?

¹

2021

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…In contrast, the binding to the endothelin B receptor ETBR results in its clearance and cellular apoptosis. In accordance, Nelson, et al reported a downregulation in aggressive variants of prostate cancers (PCa) [5]. Such down-regulation of ETBR is based on promotor methylation [3].…”

Section: Introduction

mentioning

confidence: 64%

Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer

Chen

¹

,

Ma

²

,

Liu

³

et al. 2021

J. Cancer

Smart CitationsHow this paper cites the one you are viewing

“…The treatment of PCa imposes a huge economic burden on patients and society [23]. Although many PCa patients can benefit from techniques such as prostate-specific antigen (PSA) screening, the time between tumor progression to biochemical recurrence and tumor metastasis remains unpredictable [24]. Most PCa patients eventually relapse due to castration-resistant prostate cancer, with tumor metastasis and more malignant invasive events [25].…”

Section: Discussion

mentioning

confidence: 99%

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage

¹

,

Peng

²

,

³

et al. 2018

Clin Epigenet

Abstract

Smart CitationsHow this paper cites the one you are viewing

“…CEA, CA199, and CA125 were generally accepted to be validated to have positive predictive value as circulating biomarkers for different cancers. Other screening strategies include mammography for breast cancer [ 64 , 65 ], colonoscopy for CRC [ 66 ], and prostate-specific antigen (PSA) for prostate cancer [ 67 ]. However, still missing are more effective, accurate, specific, and sensitive screening biomarkers to fulfill the detective and predictive functions in the care of cancer patients.…”

Section: The Advantage Of Circulating Mirnas As Diagnosis and Prognos

mentioning

confidence: 99%